about
ELOVL5 mutations cause spinocerebellar ataxia 38Phenotypic Heterogeneity of Monogenic Frontotemporal DementiaIntronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulatorsIs transient global amnesia a risk factor for amnestic mild cognitive impairment?Endocytosis of synaptic ADAM10 in neuronal plasticity and Alzheimer's diseaseIdentification of common variants influencing risk of the tauopathy progressive supranuclear palsy.Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation.Functional correlates of Apolipoprotein E genotype in Frontotemporal Lobar Degeneration.Latent profile analysis in frontotemporal lobar degeneration and related disorders: clinical presentation and SPECT functional correlatesCognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study.Mutual information optimization for mass spectra data alignment.Frontotemporal dementia and its subtypes: a genome-wide association study.Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration.Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degenerationMultimodal FMRI resting-state functional connectivity in granulin mutations: the case of fronto-parietal dementia.Cognitive reserve in granulin-related frontotemporal dementia: from preclinical to clinical stages.Loss of function mutations in the progranulin gene are related to pro-inflammatory cytokine dysregulation in frontotemporal lobar degeneration patients.A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathiesAnodal transcranial direct current stimulation of parietal cortex enhances action naming in Corticobasal SyndromeAdvances on biological markers in early diagnosis of Alzheimer disease.Functional serotonin 5-HTTLPR polymorphism is a risk factor for migraine with aura.A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementiaPredicting Alzheimer dementia in mild cognitive impairment patients. Are biomarkers useful?Criteria for the diagnosis of corticobasal degenerationDyslexia susceptibility genes influence brain atrophy in frontotemporal dementia.A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats.Combined biomarkers for early Alzheimer disease diagnosis.Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status.Neurofilament light chain: a biomarker for genetic frontotemporal dementiaA low-molecular-weight ferroxidase is increased in the CSF of sCJD cases: CSF ferroxidase and transferrin as diagnostic biomarkers for sCJD.Rare Variants in PLD3 Do Not Affect Risk for Early-Onset Alzheimer Disease in a European Consortium Cohort.Blood cell markers in Alzheimer Disease: Amyloid Precursor Protein form ratio in platelets.Genetic susceptibility to behavioural and psychological symptoms in Alzheimer disease.TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.New insights into biological markers of frontotemporal lobar degeneration spectrum.Genetic bases of Progressive Supranuclear Palsy: the MAPT tau disease.Clinical, biological, and imaging features of monogenic Alzheimer's Disease.Subcortical and deep cortical atrophy in Frontotemporal Lobar Degeneration.Universal grammar in the frontotemporal dementia spectrum: evidence of a selective disorder in the corticobasal degeneration syndrome.Heterozygous TREM2 mutations in frontotemporal dementia.
P50
Q24301387-E2CBF9BD-D3D4-40D5-815D-506DA4915C70Q26782984-FB0921EB-90E3-4033-A495-91F92810FDC5Q28263736-63B69A7E-BC48-4672-BE9D-C0A9673AA698Q28282613-D8FC86DB-622C-42C3-84C3-C3D89653931EQ29048183-BF878882-F653-4C1A-93B9-985F04117DC4Q29417026-3B1D5A34-875C-4E0E-A187-249033BE964FQ30754508-66BD304A-4231-4D35-B7CD-6FE0674D914AQ33255119-754BA9C0-DCEB-45F6-9388-6390BCBF126CQ33284827-7B4DA406-1FEE-4E83-997A-3725947B70ACQ33729886-C09C7B12-639D-4294-8843-12E35E77A685Q33881800-6751167B-C094-4074-87F3-5FF1E7836F5FQ33955007-44443044-5C6A-435F-B424-A23D706EBAABQ34028511-2EB572CB-83EF-4CE8-A652-07B5255CBC78Q34038343-6BF30E2A-FD56-4EA1-9F7A-EE92D8BEFEBEQ34133804-0482EE06-F8C6-47D1-9B88-6B6D09A3D4BCQ34990333-66E83C75-4C7B-4014-A880-EC4A8A931D11Q35121652-9DDA9731-3654-42BD-9CAC-EE7729B9BC03Q35206942-FB8A270B-2A2F-4231-8182-24904EB1CF77Q35409266-938558B1-024C-431B-BD1B-3B9C487C353AQ36192471-7287392D-634A-426F-8B93-50A324579EAEQ36260498-58810669-17D3-4CBF-AE0F-FEF36CD5D3E9Q36444721-CA238334-E2C3-4D85-8061-E2C713DE1BF8Q36532279-A760BEA2-A586-4871-98B5-6F1D5267AF2FQ36661843-92E07417-0359-4159-81DA-11A3A7E97E46Q36733870-1D7B4B1A-5E13-4158-B9B1-C8FCF24EE1D0Q36801066-785549C0-EA0E-4E12-96B7-397CD295C31AQ36801066-9522592E-22D4-415B-81AF-FA7AE249C709Q36822638-9C31C60D-8BE6-452A-862C-BA362A2E0932Q36901561-5AFBB9BF-FC5F-4041-A195-80BBC2A8543FQ37208495-7D7C7B04-04A2-4ECA-A6C3-9C410FB1ACD1Q37258755-EC50EC26-EF80-46D6-B9C8-400FD7FBB497Q37325871-B4FA17B5-8DB8-4A78-8EA5-E2C674190602Q37584675-7D089EFE-C82E-4C7F-BE36-622EE96FEFA7Q37588778-6A3B7D04-85DE-4BBA-9A65-C5262DDB9FDEQ37664119-881957E3-5C81-454F-B2F0-591E1DF4DB66Q37692474-52FBD235-B626-465D-850B-B49A3225821FQ37875157-D3AD0750-25EB-4199-97E8-D51D774FAF1DQ38174619-D963622F-898E-4148-9867-C460DFF3C87DQ38381052-F98ACE50-921D-44B1-A4B4-A1407DB1882AQ38396046-6ECFEBD5-5B4D-42EE-B74F-D7282B02C5AF
P50
description
researcher ORCID ID = 0000-0001-9340-9814
@en
wetenschapper
@nl
name
Barbara Borroni
@ast
Barbara Borroni
@en
Barbara Borroni
@es
Barbara Borroni
@nl
type
label
Barbara Borroni
@ast
Barbara Borroni
@en
Barbara Borroni
@es
Barbara Borroni
@nl
prefLabel
Barbara Borroni
@ast
Barbara Borroni
@en
Barbara Borroni
@es
Barbara Borroni
@nl
P106
P21
P31
P496
0000-0001-9340-9814